Relationships Between Nutrition, Alcohol Use, and Liver Disease

Many alcoholics are malnourished, either because they ingest too little of essential nutrients (e.g., carbohydrates, proteins, and vitamins) or because alcohol and its metabolism prevent the body from properly absorbing, digesting, and using those nutrients. As a result, alcoholics frequently experience deficiencies in proteins and vitamins, particularly vitamin A, which may contribute to liver disease and other serious alcohol-related disorders. Furthermore, alcohol breakdown in the liver, both by the enzyme alcohol dehydrogenase and by an enzyme system called the microsomal ethanol-oxidizing system (MEOS), generates toxic products such as acetaldehyde and highly reactive, and potentially damaging, oxygen-containing molecules. These products can interfere with the normal metabolism of other nutrients, particularly lipids, and contribute to liver cell damage. Nutritional approaches can help prevent or ameliorate alcoholic liver disease. For example, a complete balanced diet can compensate for general malnutrition. Administration of antioxidants (e.g., precursors of the endogenous antioxidant glutathione) can help the body eliminate reactive oxygen molecules and other reactive molecules generated from abnormal lipid breakdown. New agents currently are being studied as promising nutritional supplements for alcoholics with liver disease.

[1]  A. Nanji,et al.  Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. , 1996, The Journal of pharmacology and experimental therapeutics.

[2]  C. Lieber,et al.  Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. , 1967, The Journal of clinical investigation.

[3]  C. Lieber,et al.  Interactions between alcohol and beta-carotene in patients with alcoholic liver disease. , 1994, The American journal of clinical nutrition.

[4]  C. Lieber Hepatic, metabolic and toxic effects of ethanol: 1991 update. , 1991, Alcoholism, clinical and experimental research.

[5]  C. Lieber,et al.  Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. , 1997, Journal of hepatology.

[6]  C. Lieber,et al.  Quantitative relationship between amount of dietary fat and severity of alcoholic fatty liver. , 1970, The American journal of clinical nutrition.

[7]  C. Lieber Perspectives: do alcohol calories count? , 1991, The American journal of clinical nutrition.

[8]  J. Mato,et al.  S‐adenosyl‐L‐methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis , 1988, Hepatology.

[9]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[10]  D. Bunout,et al.  Effects of long-term vitamin E supplementation in alcoholic cirrhotics. , 1995, Journal of the American College of Nutrition.

[11]  C. Lieber,et al.  Interaction of ethanol with β‐carotene: Delayed blood clearance and enhanced hepatotoxicity , 1992, Hepatology.

[12]  B. Schneider,et al.  Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. , 1989, Journal of hepatology.

[13]  C. Lieber,et al.  Potentiation of ethanol-induced hepatic vitamin A depletion by phenobarbital and butylated hydroxytoluene. , 1987, Journal of NutriLife.

[14]  C. Lieber,et al.  Effects of Ethanol on Amino Acid and Protein Metabolism , 1992 .

[15]  C. Lieber,et al.  Hepatic vitamin A depletion in alcoholic liver injury. , 1982, The New England journal of medicine.

[16]  J. Rankin,et al.  Alcohol and the Liver , 1977, Springer US.

[17]  C. Lieber,et al.  Hepatic Fibrosis After Long‐Term Administration of Ethanol and Moderate Vitamin A Supplementation in the Rat , 2007, Hepatology.

[18]  P. Gartside,et al.  Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. , 1991, The American journal of gastroenterology.

[19]  C. Lieber,et al.  Increased vitamin A in esophagus and other extrahepatic tissues after chronic ethanol consumption in the rat. , 1986, Alcoholism, clinical and experimental research.

[20]  C. Lieber,et al.  Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons , 2003, Journal of clinical gastroenterology.

[21]  C. Lieber,et al.  The energy cost of the metabolism of drugs, including ethanol. , 1972, Pharmacology.

[22]  J. Li,et al.  Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. , 1994, Gastroenterology.

[23]  R. A. Holden Alcohol, nutrient intake, and hypertension. , 1985, JAMA.

[24]  J. Barboriak,et al.  Alcohol, nutrient intake, and hypertension in US adults. , 1985, JAMA.

[25]  Thomas E. Moritz,et al.  Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. , 1995, Alcoholism, clinical and experimental research.

[26]  C. Lieber,et al.  Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. , 1981, The Journal of nutrition.

[27]  Maurice E. Shils,et al.  Modern Nutrition in Health and Disease , 1965, Diabetes.

[28]  J. Casazza,et al.  Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. , 1985, The Journal of biological chemistry.

[29]  C. Lieber,et al.  Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease , 1983, Digestive Diseases and Sciences.

[30]  C. Lieber,et al.  The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro. , 1961, The Journal of clinical investigation.

[31]  C. Lieber,et al.  Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. , 1999, The American journal of clinical nutrition.

[32]  C. Lieber ALCOHOL: its metabolism and interaction with nutrients. , 2000, Annual review of nutrition.

[33]  J. Palmgren,et al.  Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. , 1996, Journal of the National Cancer Institute.

[34]  A. Rosman,et al.  The intralobular distribution of ethanol‐inducible P450IIE1 in rat and human liver , 1989, Hepatology.

[35]  C. Lieber,et al.  Cytochrome P-4502E1: its physiological and pathological role. , 1997, Physiological reviews.

[36]  C. Lieber,et al.  Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat‐storing cells through a protein synthesis–dependent mechanism , 1991, Hepatology.

[37]  A. Rosman,et al.  Differential depletion of carotenoids and tocopherol in liver disease , 1993, Hepatology.

[38]  C. Lieber S-adenosyl-L-methionine: its role in the treatment of liver disorders. , 2002, The American journal of clinical nutrition.

[39]  C. Lieber,et al.  Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression. , 1996, Journal of hepatology.

[40]  C. Lieber Hepatic and other medical disorders of alcoholism: from pathogenesis to treatment. , 1998, Journal of studies on alcohol.

[41]  J. Rodés,et al.  S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. , 1999, Journal of hepatology.

[42]  C. Lieber,et al.  Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system. , 1998, Alcoholism, clinical and experimental research.

[43]  Cho-il Kim,et al.  S‐Adenosyl‐L‐methionine attenuates alcohol‐induced liver injury in the baboon , 1990, Hepatology.

[44]  C. Lieber,et al.  Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. , 1997, Alcoholism, clinical and experimental research.

[45]  J. Panés,et al.  Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. , 1998, Journal of hepatology.